Singapore Exchange (SGX)

Broker's Calls

SGX 'leaning on' FX, commodities as equities business stays 'unexciting': analysts

“Despite robust growth from the FICC segment, we reckon that there are no near-term catalysts to justify a higher valuation.”
Following SGX's 1HFY2024 results, Citi urges 'sell', Maybank and OCBC maintain 'hold' - THE EDGE SINGAPORE

Broker's Calls

Following SGX's 1HFY2024 results, Citi urges 'sell', Maybank and OCBC maintain 'hold'

With 3.8% yield versus 5.7% for the STI, the value proposition as a growth stock versus a yield stock is “unclear at this time”.
SGX enjoys FX, iron ore derivatives boost in 1HFY2024; insists spac rules 'work' - THE EDGE SINGAPORE

Results

SGX enjoys FX, iron ore derivatives boost in 1HFY2024; insists spac rules 'work'

“For a good de-spac, you also need a conducive IPO environment. Clearly, that hasn’t really been there in the last two years.”
Two remaining SGX-listed spac firms to dissolve, ending further despac hopes (update) - THE EDGE SINGAPORE

SPACs

Pegasus Asia to dissolve its spac. Will Novo Tellus follow suit? (update)

Should the spacs be dissolved, investors’ funds will be returned.

Broker's Calls

RHB stays 'neutral' on SGX as 'the disappointment continues'

RHB notes increased trading activity on the Singapore Exchange in November, but securities data still remains below estimates.

Broker's Calls

RHB keeps SGX's TP unchanged despite its securities turnover, daily average value running 'well below estimates'

Despite factoring in a mid-single digit percentage growth in dividends, SGX’s yield is well below the market yield of 5.6%.
Will new wave of listings sway the crowd? - THE EDGE SINGAPORE

IPO

Will new wave of listings sway the crowd?

A slate of new SGX listings is poised to take place. Can the momentum continue?

IPO

IPO aspirants range from manpower for wind power to artists for Assassins

WinKing Studios, Sheffield Green and LYC Medicare are some of the IPO aspirants.

Broker's Calls

SGX's near-term growth outlook could see downside risk, RHB maintains 'neutral'

Macroeconomic uncertainty will weigh on new IPO listings and cash equity trading volume, says RHB.
×